{"DataElement":{"publicId":"2807193","version":"1","preferredName":"Protocol Treatment First Treatment Step Protocol Treatment Arm Assignment Type","preferredDefinition":"the type of treatment assigned during the specific treatment protocol used in the first arm or stage of progression through a sequential treatment protocol.","longName":"PR_TX_F_TXS_AR_AS_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2807191","version":"1","preferredName":"Protocol Treatment First Treatment Step Protocol Treatment Arm Assignment","preferredDefinition":"information related to the assignment the specific treatment protocol used in the first arm or stage of progression through a sequential treatment protocol.","longName":"PRO_TX_F_TXS_ARM_ASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2425177","version":"1","preferredName":"Protocol Therapy","preferredDefinition":"A protocol is a rule which guides how an activity should be performed; a set of formal rules used to specify the format of an exchange of data.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C42651:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol","conceptCode":"C42651","definition":"A rule which guides how an activity should be performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03E16831-B3E1-6D9B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-11-02","modifiedBy":"ONEDATA","dateModified":"2005-11-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2807189","version":"1","preferredName":"First Step Protocol Treatment Arm Assignment","preferredDefinition":"Preceding all others in time or space or degree.:Status of progression through a sequential treatment protocol:A specific treatment protocol used in a clinical trial.:Assignment; an undertaking that you have been assigned to do.","longName":"C25509:C16154:C15538:C25426","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Treatment Step","conceptCode":"C16154","definition":"A specific stage of progression through a sequential treatment protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Protocol Treatment Arm","conceptCode":"C15538","definition":"A specific treatment plan within a clinical trial that describes the activities a subject will be involved in as he or she progresses through the study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assignment","conceptCode":"C25426","definition":"An allotting or an appointment to a particular person or use, or for a particular time or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D013A12-1FDC-23E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"ONEDATA","dateModified":"2008-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D013A12-1FED-23E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2807192","version":"1","preferredName":"First Treatment Step Protocol Treatment Arm Assignment Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"F_TXST_ARM_ASS_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"AC-T","valueDescription":"Doxorubicin Cyclophosphamide + Placebo + Paclitaxel","ValueMeaning":{"publicId":"2807431","version":"1","preferredName":"Doxorubicin Cyclophosphamide + Placebo + Paclitaxel","longName":"2807431","preferredDefinition":"Doxorubicin Cyclophosphamide + Placebo + Paclitaxel","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D017112-0366-2331-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5D017683-68E3-236D-E044-0003BA3F9857","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"ONEDATA","dateModified":"2008-12-01","deletedIndicator":"No"},{"value":"BAC-BT","valueDescription":"Doxorubicin Cyclophosphamide Bevacizumab + Paclitaxel + Bevacizumab","ValueMeaning":{"publicId":"2807432","version":"1","preferredName":"Doxorubicin Cyclophosphamide Bevacizumab + Paclitaxel + Bevacizumab","longName":"2807432","preferredDefinition":"Doxorubicin Cyclophosphamide Bevacizumab + Paclitaxel + Bevacizumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D0173C5-A3D3-232F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5D017683-68F5-236D-E044-0003BA3F9857","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"ONEDATA","dateModified":"2008-12-01","deletedIndicator":"No"},{"value":"BAC-BT-B","valueDescription":"Doxorubicin Cyclophosphamide Bevacizumab + Paclitaxel + Bevacizumab + Bevacizumab","ValueMeaning":{"publicId":"2807433","version":"1","preferredName":"Doxorubicin Cyclophosphamide Bevacizumab + Paclitaxel + Bevacizumab + Bevacizumab","longName":"2807433","preferredDefinition":"Doxorubicin Cyclophosphamide Bevacizumab + Paclitaxel + Bevacizumab + Bevacizumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D0175B6-0349-2371-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5D017683-6907-236D-E044-0003BA3F9857","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"ONEDATA","dateModified":"2008-12-01","deletedIndicator":"No"},{"value":"A:  Lenalidomide Monotherapy","valueDescription":"A:  Lenalidomide Monotherapy","ValueMeaning":{"publicId":"3012880","version":"1","preferredName":"A:  Lenalidomide Monotherapy","longName":"3012880","preferredDefinition":"A:  Lenalidomide Monotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FE5C47F-3C87-E321-E040-BB89AD432EF0","latestVersionIndicator":"Yes","beginDate":"2010-02-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-02-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FE5C6E7-4FB0-9771-E040-BB89AD432CAE","beginDate":"2010-02-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-02-18","modifiedBy":"ONEDATA","dateModified":"2010-02-18","deletedIndicator":"No"},{"value":"B:  Lenalidomide + Epoetin Alfa","valueDescription":"B:  Lenalidomide + Epoetin Alfa","ValueMeaning":{"publicId":"3012881","version":"1","preferredName":"B:  Lenalidomide + Epoetin Alfa","longName":"3012881","preferredDefinition":"B:  Lenalidomide + Epoetin Alfa","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FE5C975-1992-BBD3-E040-BB89AD4356B9","latestVersionIndicator":"Yes","beginDate":"2010-02-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-02-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FE5CB2A-9C68-8409-E040-BB89AD432CB6","beginDate":"2010-02-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-02-18","modifiedBy":"ONEDATA","dateModified":"2010-02-18","deletedIndicator":"No"},{"value":"Arm C - Cabozantinib and Erlotinib","valueDescription":"Arm C - Cabozantinib and Erlotinib","ValueMeaning":{"publicId":"3687471","version":"1","preferredName":"Arm C - Cabozantinib and Erlotinib","longName":"3687471","preferredDefinition":"Arm C - Cabozantinib and Erlotinib","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5DA0EFE-9F84-F18D-E040-BB89AD436426","latestVersionIndicator":"Yes","beginDate":"2013-02-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5DA0EFE-9F9D-F18D-E040-BB89AD436426","beginDate":"2013-02-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-02-16","modifiedBy":"ONEDATA","dateModified":"2013-02-16","deletedIndicator":"No"},{"value":"Arm B - Cabozantinib","valueDescription":"Arm B - Cabozantinib","ValueMeaning":{"publicId":"3687472","version":"1","preferredName":"Arm B - Cabozantinib","longName":"3687472","preferredDefinition":"Arm B - Cabozantinib","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5DA0EFE-9FA7-F18D-E040-BB89AD436426","latestVersionIndicator":"Yes","beginDate":"2013-02-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5DA0EFE-9FC0-F18D-E040-BB89AD436426","beginDate":"2013-02-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-02-16","modifiedBy":"ONEDATA","dateModified":"2013-02-16","deletedIndicator":"No"},{"value":"Arm A - Erlotinib","valueDescription":"Arm A - Erlotinib","ValueMeaning":{"publicId":"3687473","version":"1","preferredName":"Arm A - Erlotinib","longName":"3687473","preferredDefinition":"Arm A - Erlotinib","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5DA0EFE-9FCA-F18D-E040-BB89AD436426","latestVersionIndicator":"Yes","beginDate":"2013-02-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5DA0EFE-9FE3-F18D-E040-BB89AD436426","beginDate":"2013-02-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-02-16","modifiedBy":"ONEDATA","dateModified":"2013-02-16","deletedIndicator":"No"},{"value":"Arm B: Dabrafenib + Trametinib","valueDescription":"Arm B: Dabrafenib + Trametinib","ValueMeaning":{"publicId":"4736491","version":"1","preferredName":"Arm B: Dabrafenib + Trametinib","longName":"4736491","preferredDefinition":"Arm B: Dabrafenib + Trametinib","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10A45020-48C8-187D-E050-BB89AD432800","latestVersionIndicator":"Yes","beginDate":"2015-03-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10A45020-48E1-187D-E050-BB89AD432800","beginDate":"2015-03-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-06","modifiedBy":"ONEDATA","dateModified":"2015-03-06","deletedIndicator":"No"},{"value":"Arm A: Nivolumab + Ipilimumab","valueDescription":"Arm A: Nivolumab + Ipilimumab","ValueMeaning":{"publicId":"4736492","version":"1","preferredName":"Arm A: Nivolumab + Ipilimumab","longName":"4736492","preferredDefinition":"Arm A: Nivolumab + Ipilimumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10A45020-48EB-187D-E050-BB89AD432800","latestVersionIndicator":"Yes","beginDate":"2015-03-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10A45020-4904-187D-E050-BB89AD432800","beginDate":"2015-03-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-06","modifiedBy":"ONEDATA","dateModified":"2015-03-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D013A12-2000-23E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"ROUILLAS","dateModified":"2015-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Which treatment did the patient receive (on step 1)","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Which treatment arm did the patient receive on step 1 of treatment","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D014DBC-5E07-2328-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-01","modifiedBy":"ALAIS","dateModified":"2010-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}